Pharmaceutical Product Supply – Methocarbamol Tablets

The contract pertains to the manufacture and supply of three bottles of Methocarbamol Tablets, each containing 500 mg per tablet, identified by the National Stock Number 6505006601601. The product must fully comply with all applicable FDA regulations, current Good Manufacturing Practices, and Defense Logistics Agency standards to ensure quality, safety, and regulatory adherence. This is a subcontract under the Department of Defense, specifically managed by the Defense Logistics Agency, with the North American Industry Classification System code 325412 indicating pharmaceutical manufacturing. The contract was posted on July 14, 2026, and the performance location and point of contact details are not specified, though the award information can be accessed through the DIBBS system via the provided link. The scope is narrowly defined to this specific pharmaceutical item, with no indication of broader procurement or multi-year obligations.